Inventor · disambiguated record
Alain Constancis
Also filed as: CONSTANCIS ALAIN
10 granted patents·9 pending applications·331 citations·filing 1994–2023
91Inventor score
Files withFLAMEL TECH SA4EXELA STERILE MEDICINES LLC3FLAMEL IRELAND LTD3AVADEL LEGACY PHARMACEUTICALS LLC2FLAMEL TECHNOLOGIES S A2
Top patents by PatentIndex Score
19 records- 0194US10543186B1Cysteine composition and injectionFLAMEL IRELAND LTD·Filed 2019·Granted Jan 28, 2020·20 cites·28 claims
- 0294US10493051B1Cysteine composition and injectionFLAMEL IRELAND LTD·Filed 2019·Granted Dec 3, 2019·22 cites·27 claims
- 0394USRE46686EPharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applicationsFLAMEL IRELAND LTD·Filed 2016·Granted Jan 30, 2018·36 cites·74 claims
- 0492US8679540B2Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applicationsBONNET-GONNET CECILE·Filed 2007·Granted Mar 25, 2014·53 cites·35 claims
- 0586US6790438B1Cross-linked collagenic peptide for preventing post-surgical adhesionsFLAMEL TECH SA·Filed 2000·Granted Sep 14, 2004·55 cites·27 claims
- 0682US2024033239A1Cysteine composition and injectionEXELA STERILE MEDICINES LLC·Filed 2023·Application pending·0 cites
- 0779US10702490B1Cysteine composition and injectionAVADEL LEGACY PHARMACEUTICALS LLC·Filed 2019·Granted Jul 7, 2020·1 cites·30 claims
- 0878US5496872AAdhesive compositions for surgical useIMEDEX·Filed 1994·Granted Mar 5, 1996·113 cites·17 claims
- 0975US11045438B2Cysteine composition and injectionEXELA STERILE MEDICINES LLC·Filed 2019·Granted Jun 29, 2021·0 cites·28 claims
- 1070US2021137869A1Cysteine composition and injectionEXELA STERILE MEDICINES LLC·Filed 2020·Application pending·0 cites
- 1164US2010021549A1Microparticle oral form useful for the modified release of nanoparticlesFLAMEL TECHNOLOGIES S A·Filed 2009·Application pending·0 cites
- 1264US2008102128A1Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising themFLAMEL TECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 1361US2014105993A1Modified-release microparticles based on amphiphilic copolymer and on active principle(s) and pharmaceutical formulations comprising themFLAMEL TECHNOLOGIES S A·Filed 2013·Application pending·0 cites
- 1458US8017156B2Long-acting colloidal insulin formulation and its preparationFLAMEL TECH SA·Filed 2005·Granted Sep 13, 2011·0 cites·12 claims
- 1557US2008175921A1Colloidal formulation of long-acting insulin and its preparationCONSTANCIS ALAIN·Filed 2007·Application pending·0 cites
- 1650US5646239AOrganic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said productsFLAMEL TECH SA·Filed 1994·Granted Jul 8, 1997·31 cites·43 claims
- 1745US2011129540A1Polymer of acrylic or methacrylic type comprising alpha-tocopherol graftsFLAMEL TECH SA·Filed 2010·Application pending·0 cites
- 1842US2012156257A1Method for the preparation of nanoparticlesDROGOZ ALEXANDRE·Filed 2011·Application pending·0 cites
- 1941US2022133647A1Liquid guaifenesin compositions with stable extended release profilesAVADEL LEGACY PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alain Constancis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →